LBI-HTA - Publications - Search - Horizon Scanning in Oncology: Results of the 30th Prioritisation – 1st quarter 2017

Grössmann, N. and Wolf, S. (2017): Horizon Scanning in Oncology: Results of the 30th Prioritisation – 1st quarter 2017. HSO: 30th Prioritisation.

[img]PDF - Sie müssen einen PDF-Viewer auf Ihrem PC installiert haben wie z. B. GSview, Xpdf oder Adobe Acrobat Reader
130Kb
Abstract

For the 30 prioritisation (February 2017), 12 drugs were filtered out of 301 identified and were sent to prioritisation. Of these, 5 drugs were ranked as 'highly relevant' by the expert panel, 7 as 'relevant' and 0 as 'not relevant'. For 'highly relevant' drugs, further information including, for example, abstracts of phase III studies and licensing status is contained in this document.

Item Type:DSD: Horizon Scanning in Oncology
Subjects:WB Practice of medicine > WB 300-962 Therapeutics
QZ Pathology > QZ 200-380 Neoplasms.Cysts
QV Pharmacology, toxicology, pharmacy > QV 60-370 Pharmacology
Language:English
Series Name:HSO: 30th Prioritisation
Deposited on:27 Mar 2017 13:09
Last Modified:27 Mar 2017 13:09

Repository Staff Only: item control page